Novel Terahertz Sensing and Imaging Systems for Biotechnology, Healthcare, Security and Process Monitoring

Description

TeraNova will realise new functional components and systems for the unexploited Terahertz region of the electromagnetic spectrum lying between the millimetre wave and infrared, and in doing so, will deliver substantial benefits to the lives of its citizens. Advanced solid-state sources will be developed, including QC lasers and broadband sources, and sensitive detectors. These low-cost, compact, functional components will be used in sensing and imaging systems to solve specific problems identified in European biotechnology, security, healthcare, and high technology industries. By exploiting new opportunities and responding to emerging needs, we will address research challenges for 2010 and beyond in: Healthcare and Life Science - developing highly sensitive genetic mutation sensors, and a microscope to probestructure and function of living cells in a revolutionary way; Environment and Security - developing sensing systems for explosives, drugs and harmful chemicals; Industrial Processes - developing technologies to assess semiconductor wafers as they are manufactured. TeraNova will strengthen the European Research Area, ensure wealth-creation via comprehensive Exploitation and Dissemination, and engage in programmes to stimulate new developments and train the future workforce. TeraNova will integrate European capabilities, taking concepts through to Community End Users from industry, healthcare, security agencies and academia. Research and development will involve large-scale Industry, SMEs and Academics, reinforcing European strengths where it has established industrial and technology leadership. TeraNova will be organised thematically, will be governed democratically, and will have an eminent industrialist as Chair providing end-user pull.
AcronymTeraNova
StatusFinished
Effective start/end date01/09/200431/08/2008